Celebrating 20 years of iGEM at the 2023 Grand Jamboree

The iGEM 2023 Grand Jamboree brought together over 3500 people to celebrate 20 years of iGEM, the heart of synthetic biology. This was the largest event to date, attended by synthetic biology researchers, industry reps, startup founders, investors, journalists, experts in governance and policy, and the general public, to glimpse the future of synthetic biology.

The iGEM 2023 BioInnovation Fair: Meet the BioFounders changing the world for the better

We believe that to change the world for the better, BioFounders need to be empowered globally. That’s why we are excited to announce the BioInnovation Fair at the iGEM 2023 Grand Jamboree! Please join us at this thrilling event where you’ll come together with synbio industries, media, startups, incubators, investors, and other stakeholders to connect, network, and forge game-changing deals.

Responsibility Conference 2.0: Having the conversations that can’t happen anywhere else

At iGEM, people can freely think about the future, and most importantly, how they want to get there. We invite you to join us at the second edition of the Responsibility Conference at the 2023 iGEM Grand Jamboree. The conference offers a platform for multi-stakeholder engagement to deliberate ongoing initiatives and emerging concerns in the realms of biorisk, biosecurity, and biosafety. 

On the road to Paris: Paris Handbook for iGEMers, by iGEMers

Tomorrow is the iGEM 2023 wiki freeze – a moment each and every iGEM team experiences and remembers long after the freeze has passed. During these final moments before the freeze, and in the days ahead, we thought you might enjoy looking forward to some of the fun and cool things that await you in Paris. While you won’t want to miss a moment of the Grand Jamboree, there’s much to enjoy in Paris if you arrive early or stay a bit longer.

GenScript's partnership with iGEM: Investing in a brighter future with synthetic biology

GenScript's founders recognized that limited access to high-quality and reliable reagents significantly restricted advances in life science research. Therefore, for over 20 years, GenScript has developed, adopted, and improved upon many innovative synthetic biology technologies, expanded its footprint, and established partnerships with scientists globally. Among these partnerships, GenScript's connection with the iGEM community is of particular significance. iGEM enables aspiring young scientists to imagine and collaborate in creating solutions for a brighter future with synthetic biology.